Search

Search Constraints

You searched for: Author/Creator Fu, Min

Search Results

70. Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma. Issue 12 (23rd December 2020)